Abiopharma

JD Investors Have Opportunity to Join JD.com, Inc. Fraud Investigation with the Schall Law Firm

BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing

BetterLife Engages Syner-G to Oversee GMP Manufacturing of BETR-001 for IND and Phase 1

ELTX Investors Have Opportunity to Join Elicio Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

PlasCred Secures Conditional Long-Term CN Rail Lease for Advanced Recycling Facility

NextNav Reminds Investors of Redemption of Public Warrants

MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses

BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity

MSCI公布MSCI 2026年市場分類評審結果

Became an interested party – Meitav Investment House Ltd.